Effects of eating nuts on obese diabetic women
Influence of Acute Nut Intake on the Effects of High Saturated Fat Meals in Obese Diabetic Women
This study tests if eating walnuts can help obese women with type 2 diabetes reduce inflammation and stress in their bodies after eating high-fat meals.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | UPECLIN HC FM Botucatu Unesp Academic / other |
| Locations | 1 site (Botucatu, São Paulo) |
| Trial ID | NCT06710340 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of acute walnut consumption on inflammatory responses and oxidative stress in obese women with type 2 diabetes. It aims to understand how walnuts may help mitigate the negative health effects associated with high saturated fat meals, which are linked to obesity and diabetes. Participants will consume nuts during two separate meetings, and their metabolic responses will be monitored to assess the potential benefits of walnut intake. The research focuses on the relationship between diet, obesity, and chronic diseases, particularly in the context of Brazil's rising obesity rates.
Who should consider this trial
Good fit: Ideal candidates for this study are women over 18 years old who are diagnosed with obesity and non-insulin-dependent type 2 diabetes.
Not a fit: Patients with insulin-dependent diabetes, cancer, or other significant health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into dietary interventions that help manage obesity and type 2 diabetes in women.
How similar studies have performed: While there is ongoing research into dietary interventions for obesity and diabetes, this specific approach focusing on walnuts is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women over 18 years of age * Diagnosis of obesity (body mass index \[BMI \>30 kg/m²\]) * Diagnosis of non-insulin-dependent type II diabetes Exclusion Criteria: * Use of dietary supplements or corticosteroid use in the last 3 months * Diagnosis of insulin dependent diabetes * Diagnosis of cancer * Diagnosis of heart failure * Diagnosis of kidney diseases * Diagnosis of liver diseases * Diagnosis of lung diseases * Diagnosis ofneurological diseases * Diagnosis of allergy to any component of the high saturated fat meal or walnuts
Where this trial is running
Botucatu, São Paulo
- São Paulo State University (UNESP), Medical School, Botucatu — Botucatu, São Paulo, Brazil (Recruiting)
Study contacts
- Principal investigator: Marcos M Ferreira, PhD — FMB/Unesp
- Study coordinator: Raquel S Ballarin, M.D.
- Email: raquel.ballarin@unesp.br
- Phone: 5514997864806
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.